[PDF][PDF] Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis

V Arroyo, P Gines, AL Gerbes, FJ Dudley… - …, 1996 - Wiley Online Library
During the last decade great advances have been made of water retention and dilutional
hyponatremia in human cirrhosis. Finally, the field of spontaneous infection of concerning …

Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis

G Garcia–Tsao - Gastroenterology, 2001 - Elsevier
Portal hypertension is the main complication of cir-rhosis because it is directly responsible
for two of its most common and potentially lethal complications: variceal hemorrhage and …

Guidelines on the management of ascites in cirrhosis

KP Moore, GP Aithal - Gut, 2006 - gut.bmj.com
Ascites is a major complication of cirrhosis, 1 occurring in 50% of patients over 10 years of
follow up. 2 The development of ascites is an important landmark in the natural history of …

[КНИГА][B] Sherlock's diseases of the liver and biliary system

JS Dooley, AS Lok, G Garcia-Tsao, M Pinzani - 2018 - books.google.com
A new, fully updated edition of the world's most famous book on liver diseases—with
updating of all areas and inclusion of new specific topics, by internationally renowned …

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems

M Guevara, P Ginès, JC Bandi, R Gilabert, P Sort… - Hepatology, 1998 - journals.lww.com
Little information exists on the effects of transjugular intrahepatic portosystemic shunts
(TIPS) in the management of cirrhotic patients with hepatorenal syndrome (HRS). The …

[КНИГА][B] Hepatology Principles and Practice: History· Morphology Biochemistry· Diagnostics Clinic· Therapy

E Kuntz - 2006 - Springer
Metabolic processes utilize a variety of differing and contrasting biochemical routes to
enable synthesis of degradation and activation or deactivation of substances; in addition …

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

D Lebrec, N Giuily, A Hadengue, V Vilgrain… - Journal of …, 1996 - Elsevier
Background/Aims: Transjugular intrahepatic portosystemic shunts reduce portal pressure
and can control ascites in patients with cirrhosis. We carried out a controlled study to …

The transjugular intrahepatic portosystemic stent–shunt procedure for refractory ascites

A Ochs, M Rössle, K Haag… - … England Journal of …, 1995 - Mass Medical Soc
Background Previous studies have suggested that the transjugular placement of an
intrahepatic stent to establish a portosystemic shunt is an effective treatment of …

Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a …

Y Narahara, H Kanazawa, T Fukuda… - Journal of …, 2011 - Springer
Background Transjugular intrahepatic portosystemic shunt (TIPS) has recently been
reported to be effective in the treatment of cirrhotic patients with refractory ascites. However …

TIPS versus paracentesis for cirrhotic patients with refractory ascites

S Saab, JM Nieto, SK Lewis… - Cochrane Database of …, 2006 - cochranelibrary.com
Background Refractory ascites (ie, ascites that cannot be mobilized despite sodium
restriction and diuretic treatment) occurs in 10 per cent of patients with cirrhosis. It is …